BIOHAVEN
BHVN Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-05
2025-05-07
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2024-10-02
2024-10-03
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
21,052
$48.00
1.01M
1
$1.61B
2024-06-17
2024-06-20
CAR BRUCE
Chief Scientific Officer
P - Purchase
Common Shares
30,000
$34.00
1.02M
1
$1.61B
2024-04-30
2024-05-02
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-22
2024-04-23
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
122K
$41.00
5.00M
1
$1.61B
2024-01-02
2024-01-04
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2024-01-02
2024-01-04
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2024-01-02
2024-01-04
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
27,500
$0.00
1
$1.61B
2024-01-02
2024-01-04
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
275K
$0.00
1
$1.61B
2024-01-02
2024-01-04
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2023-12-29
2023-12-29
ANTONIJEVIC IRINA
M - Exercise
Stock Options (Right to Buy)
-11,000
$0.00
1
$1.61B
2023-11-02
2023-11-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
22,500
$0.00
1
$1.61B
2023-11-02
2023-11-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
225K
$0.00
1
$1.61B
2023-11-02
2023-11-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
225K
$0.00
1
$1.61B
2023-11-02
2023-11-06
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
22,500
$0.00
1
$1.61B
2023-11-02
2023-11-06
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-10-05
2023-10-10
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
114K
$22.00
2.50M
1
$1.61B
2023-10-05
2023-10-10
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Share
341K
$22.00
7.50M
1
$1.61B
2023-10-05
2023-10-06
BUTEN MATTHEW
Chief Financial Officer
P - Purchase
Common Shares
22,727
$22.00
500K
1
$1.61B
2023-05-02
2023-05-04
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2022-10-31
2022-11-01
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Stock
25,800
$16.00
413K
1
$1.61B
2022-10-28
2022-10-31
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
142K
$15.00
2.13M
2
$1.61B
2022-10-25
2022-10-26
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
853K
$11.00
9.39M
1
$1.61B
2022-10-25
2022-10-26
BUTEN MATTHEW
Chief Financial Officer
P - Purchase
Common Shares
143K
$11.00
1.57M
1
$1.61B
2022-10-05
2022-10-06
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
486K
$10.00
4.86M
9
$1.61B
2022-10-03
2022-10-05
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.
J - Other
Common Shares
36M
$0.00
1
$1.61B
2022-10-03
2022-10-05
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.
J - Other
Common Shares
-36M
$0.00
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
J - Other
Stock Options (Right to Buy)
13,000
2
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
J - Other
Common Shares
21,838
$0.00
2
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
J - Other
Stock Options (Right to Buy)
586K
14
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
J - Other
Stock Options (Right to Buy)
116K
12
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
J - Other
Common Shares
17,951
$0.00
4
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Stock Options (Right to Buy)
-13,000
$0.00
2
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
13,000
$6.00
78,000
2
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Stock Option (Right to Buy)
-258K
$0.00
5
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
586K
$1.00
586K
14
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Options (Right to Buy)
-98,510
$0.00
10
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
116K
$2.00
231K
12
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
M - Exercise
Stock Options (Right to Buy)
-23,217
$0.00
3
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-329K
$0.00
9
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Option (Right to Buy)
-12,500
$0.00
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Options (Right to buy)
-4,500
$0.00
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to Buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to Buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
950K
$0.00
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-11,042
$8.00
-88,336
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-37,492
$7.00
-262K
1
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Restricted Share Unit Award
-106K
8
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Restricted Share Unit Award
-37,500
1
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-26,000
2
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Common Shares
-6,177
$149.00
-920K
1
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Restricted Share Unit Award
-21,750
5
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-33,375
9
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Common Shares
-4,292
$149.00
-640K
1
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Restricted Share Unit Award
-22,000
3
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-253K
12
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Common Shares
-22,362
$149.00
-3.33M
1
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-1.17M
14
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Common Shares
-923K
$149.00
-138M
4
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Restricted Share Unit Award
-20,950
3
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Stock Options (Right to Buy)
-279K
10
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Stock Options (Right to buy)
-83,792
1
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Common Shares
-15,900
$149.00
-2.37M
1
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Restricted Share Unit Award
-24,250
3
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Stock Options (Right to Buy)
-231K
12
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Common Shares
-11,653
$149.00
-1.74M
1
$1.61B
2022-10-03
2022-10-03
HEFFERNAN MICHAEL THOMAS
D - Sale to Issuer
Restricted Share Unit Award
-3,320
1
$1.61B
2022-10-03
2022-10-03
HEFFERNAN MICHAEL THOMAS
D - Sale to Issuer
Stock Options (Right to Buy)
-46,435
3
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Restricted Share Unit Award
-24,250
3
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Stock Options (Right to Buy)
-150K
8
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Common Shares
-14,226
$149.00
-2.12M
1
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Restricted Share Unit Award
-27,063
6
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-176K
14
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Common Shares
-16,464
$149.00
-2.45M
2
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Restricted Share Unit Award
-6,375
3
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-120K
11
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Common Shares
-6,682
$149.00
-996K
2
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-2,250
$0.00
1
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,250
$54.00
122K
1
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-4,200
$142.00
-596K
1
$1.61B
2022-04-28
2022-04-29
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-5,670
$0.00
2
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
5,670
$47.00
266K
2
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-9,375
$117.00
-1.10M
4
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-464
$129.00
-59,856
1
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-1,000
$0.00
1
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,000
$0.00
1
$1.61B
2022-01-10
2022-01-12
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
937
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
40,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
13,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Employee Stock Option (right to buy)
10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
5,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
23,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
11,500
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
A - Grant
Restricted Share Unit Award
13,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
2
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
A - Grant
Employee Stock Option (right to buy)
7,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
A - Grant
Restricted Share Unit Award
3,500
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-522
$129.00
-67,338
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-4,634
$129.00
-598K
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
F - Tax
Common Shares
-1,279
$129.00
-165K
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-1,631
$129.00
-210K
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,539
$129.00
-199K
1
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-342
$129.00
-44,118
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-1,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Restricted Share Unit Award
-3,250
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
2
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-875
$0.00
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,854
$124.00
-726K
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
F - Tax
Common Shares
-1,800
$124.00
-223K
1
$1.61B
2022-01-06
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
2
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-409
$124.00
-50,716
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-12,500
$0.00
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
875
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-875
$0.00
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-551
$124.00
-68,324
1
$1.61B
2022-01-06
2022-01-07
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,838
$124.00
-228K
1
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-2,230
$124.00
-277K
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,800
$124.00
-223K
1
$1.61B
2022-01-06
2022-01-07
ENGELHART JAMES
Strategic Advisor
F - Tax
Common Shares
-1,532
$124.00
-190K
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B
2022-01-06
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-12,500
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-6,323
$138.00
-873K
1
$1.61B
2021-12-20
2021-12-22
HEFFERNAN MICHAEL THOMAS
A - Grant
Restricted Share Unit Award
3,320
$0.00
1
$1.61B
2021-12-20
2021-12-22
GREGORY JULIA
M - Exercise
Employee Stock Option (Right to Buy)
-12,000
$0.00
1
$1.61B
2021-12-20
2021-12-22
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-1,915
$124.00
-237K
1
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-21,919
$0.00
2
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
S - Sale
Common Shares
-21,919
$105.00
-2.30M
2
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
21,919
$14.00
307K
2
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
S - Sale
Common Shares
-6,939
$105.00
-729K
1
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-6,939
$0.00
2
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
6,939
$16.00
111K
2
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
S - Sale
Common Shares
-35,000
$103.00
-3.60M
3
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Employee Stock Option (Right to Buy)
-35,000
$0.00
1
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
35,000
$0.00
1
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-2,318
$116.00
-269K
1
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
10,950
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,075
$116.00
-589K
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
F - Tax
Common Shares
-1,715
$116.00
-199K
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,738
$116.00
-202K
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-1,305
$116.00
-151K
1
$1.61B
2021-11-25
2021-11-26
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,599
$116.00
-185K
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-492
$116.00
-57,072
1
$1.61B
2021-11-25
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-10,950
$0.00
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-3,700
$0.00
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
3,700
$0.00
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-3,375
$0.00
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B
2021-11-23
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
10,885
$36.00
392K
2
$1.61B
2021-11-23
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,915
$32.00
61,280
1
$1.61B
2021-11-23
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-10,885
$0.00
2
$1.61B
2021-11-23
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-1,915
$0.00
1
$1.61B
2017-12-07
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
42,612
$0.00
1
$1.61B
2021-05-05
2021-05-07
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2020-01-31
2021-03-26
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (right to buy)
26,200
$0.00
1
$1.61B
2020-06-17
2021-03-05
CONWAY CHARLES
Chief Scientific Officer
S - Sale
Common Shares
-4,000
$72.00
-288K
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Employee Stock Option (right to buy)
40,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
100K
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
50,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Restricted Share Unit Award
20,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
A - Grant
Restricted Share Unit Award
20,000
$0.00
2
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
A - Grant
Employee Stock Option (right to buy)
10,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
A - Grant
Restricted Share Unit Award
5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,802
$83.00
-482K
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-2,124
$83.00
-176K
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-492
$83.00
-40,836
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-12,500
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
2
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B